PLM Implementation for Medical Device Manufacturers

PLM integrates with QMS to link field complaints, adverse events, and MDRs (medical device reports) back to design. When issues emerge post-market, you can quickly identify which design version, which manufacturing lots, and which patients are affected. This enables rapid investigation, determination of root cause, and implementation of CAPAs—all with complete traceability for FDA.

Most medical device companies still have partial paper DHFs. We help digitize critical historical data (requirements, test reports, validation) while establishing all-digital processes going forward. You don't need to digitize decades of history—just what's needed for current products and regulatory submissions.

Combination products require managing both device design history and drug formulation/stability data. We structure PLM to handle device components (mechanical, electrical) and drug components (formulation, excipients, stability studies) with appropriate controls for each. Integration with life sciences systems (like Veeva) may be needed for drug CMC data.

Yes. Submission preparation is faster because Design History Files are kept current in PLM, not compiled by hand before submission. When FDA requests additional information, you can pull it immediately from PLM rather than searching through file cabinets and spreadsheets.

Class III (highest risk) requires more rigorous traceability, design controls, and documentation. PLM must support complete requirements traceability, formal design reviews, extensive validation, and lot-level tracking. Class I (lower risk) has simpler requirements but still needs basic traceability and change control. We configure PLM complexity to match your device classification—no over-engineering.

Medical device implementations take longer than in most industries because of validation requirements and regulatory scrutiny. The work includes the Design History File structure, validation protocols (IQ/OQ/PQ), integration with QMS and ERP, and FDA audit preparation. Rushing it raises the risk of audit findings. We give you a timeline after discovery.

Yes. PLM tracks component lot numbers through BOM levels, links lots to specific production runs, and connects finished devices to patient records (when integrated with hospital systems or registries). For implantable devices, you can trace from patient back through manufacturing to raw material supplier. This is critical for recalls, adverse event reporting, and post-market surveillance.

PLM provides the electronic record and signature controls FDA requires—audit trails showing who changed what and when, role-based access controls, and validation documentation. Our implementations include automated Design History File generation, complete traceability from requirements through production, and integration with QMS for closed-loop quality management.

A Design History File (DHF) is the set of records that shows how a finished medical device was designed. FDA requires these design control records under its Quality Management System Regulation (21 CFR Part 820, which incorporates ISO 13485 clause 7.3); many companies still call the set the DHF. It must demonstrate that the device was developed in accordance with the approved design plan and design input requirements.

The DHF contains:

• Design and development plan
• Design inputs (requirements, specifications)
• Design outputs (drawings, BOMs, software specifications)
• Design review records
• Design verification records (test protocols and results)
• Design validation records
• Design transfer documents
• Design changes with approvals

How PLM manages the DHF:
A PLM system like Windchill serves as the system of record for the DHF by:

• Storing all design documents with version control and audit trail
• Linking change records (ECOs) to affected design outputs
• Providing workflow-enforced design review with digital signatures (21 CFR Part 11 compliant)
• Generating audit-ready reports showing complete design history for a device

The DHF in PLM is not a single folder — it is the configured PLM environment itself, with linked objects providing the complete traceable record. FDA inspectors increasingly expect DHFs to be accessible electronically in PLM rather than in paper binders.